Cancer remains the leading cause of death worldwide despite the enormous efforts that are
made in the development of cancer biology and anticancer therapeutic treatment …

Lung cancer affects over 1. 8 million people worldwide and is the leading cause of cancer
related mortality globally. Currently, diagnosis of lung cancer involves a combination of …

Gut epithelial organoids are routinely used to investigate intestinal biology; however, current
culture methods are not amenable to genetic manipulation, and it is difficult to generate …

Circulating tumor cells (CTCs) are important clinical indicators for prognosis and treatment
efficacy. However, CTC investigation is hampered by their low number, making the …

Circulating tumor cells (CTCs) represent an interesting source of biomarkers for diagnosis,
prognosis, and the prediction of cancer recurrence, yet while they are extensively studied in …

Whilst locoregional control of head and neck cancers (HNCs) has improved over the last
four decades, long-term survival has remained largely unchanged. A possible reason for this …

Simple Summary The conventional methods that seek to predict clinical treatment response
are based on the number of circulating tumor cells (CTCs) present in liquid biopsies or …

Multimodal analysis of circulating tumour cells (CTCs) has the potential to provide
remarkable insight for cancer development and metastasis. CTCs and CTC clusters …

There is growing awareness for the need of early diagnostic tools to aid in point-of-care
testing in cancer. Tumor biopsy remains the conventional means in which to sample a tumor …

Circulating tumor cells (CTCs) that are detached from the tumor can be precursors of
metastasis. The majority of studies focus on enumeration of CTCs from patient blood to …